Related Articles
Enhancement of lymphokine-activated killer cell induction using anti-CD25 and anti-CTLA-4 monoclonal antibodies
SYNERGY OF INTERLEUKIN-5 WITH INTERLEUKIN-2 IN THE GENERATION OF LYMPHOKINE-ACTIVATED KILLER-CELLS
Evaluation of inflammatory cytokines in malignant and benign pleural effusions.
Dysregulation of telomerase activity and expression in lymphokine-activated killer cells from advanced cancer patients: Possible involvement in cancer-associated immunosuppression mechanism
Cisplatin modulates tumor cell susceptibility to tumor-infiltrating lymphocytes in vivo